» Articles » PMID: 10993999

Spinocerebellar Ataxia Type 2 with Parkinsonism in Ethnic Chinese

Overview
Journal Neurology
Specialty Neurology
Date 2000 Sep 20
PMID 10993999
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the clinical and molecular genetic analysis of a large family of northern Chinese descent with a mutation at the SCA2 locus causing carbidopa-levodopa-responsive parkinsonism.

Background: Most causes of parkinsonism remain unknown. However, molecular genetic analysis of families with parkinsonism has recently identified five distinct loci and pathogenic mutations in four of those. Additionally, some of the spinocerebellar ataxia syndromes (SCA), particularly Machado-Joseph syndrome (SCA3), are known to cause parkinsonism. Spinocerebellar ataxia type 2 (SCA2) has not previously been described as causing a typical dopamine-responsive asymmetric PD phenotype.

Methods: A large family was evaluated clinically and molecularly for apparent autosomal dominant parkinsonism.

Results: The phenotype includes presentation consistent with typical dopamine-responsive parkinsonism. Other presentations in this family include a parkinsonism/ataxia phenotype, which is classic for SCA2 and parkinsonism, resembling progressive supranuclear palsy.

Conclusions: Patients presenting with a family history of parkinsonism, including familial progressive supranuclear palsy and PD, should be tested for the spinocerebellar ataxia type 2 expansion.

Citing Articles

Spinocerebellar Ataxia Type 2: A Review and Personal Perspective.

Pulst S Neurol Genet. 2025; 11(1):e200225.

PMID: 39872677 PMC: 11772019. DOI: 10.1212/NXG.0000000000200225.


The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.

Costa R, Conceicao A, Matos C, Nobrega C Cell Death Dis. 2024; 15(6):415.

PMID: 38877004 PMC: 11178924. DOI: 10.1038/s41419-024-06812-5.


Transcranial Sonography Characteristics of Cerebellar Neurodegenerative Ataxias.

Tamas O, Mijajlovic M, Svabic T, Kostic M, Maric G, Milovanovic A Brain Sci. 2024; 14(4).

PMID: 38671992 PMC: 11048096. DOI: 10.3390/brainsci14040340.


Clinical features, disease progression, and nuclear imaging in ATXN2-related parkinsonism in a longitudinal cohort.

Xu Y, Zhou X, Wei S, Liu F, Zhao J, Tang Y Neurol Sci. 2024; 45(7):3191-3200.

PMID: 38340219 DOI: 10.1007/s10072-024-07383-1.


Detection and discovery of repeat expansions in ataxia enabled by next-generation sequencing: present and future.

Rafehi H, Bennett M, Bahlo M Emerg Top Life Sci. 2023; 7(3):349-359.

PMID: 37733280 PMC: 10754322. DOI: 10.1042/ETLS20230018.